Biogen Inc. (BIIB) Discounted Future Market Cap - Discounting Cash Flows
Biogen Inc.
BIIB (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 186.3 USD
Estimated net income 2.79 Bil. USD
Estimated market capitalization 34.54 Bil. USD
Market capitalization discounted to present 27.21 Bil. USD
Shares Outstanding 146.1 Mil.
Earnings Per Share (EPS) 10.16 USD
Market Price 125.6 USD
Price to Earnings (PE) Ratio 12.4

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 9,676 9,816 10,312 10,497 10,687 10,879 11,075
Revenue Growth Rate -1.62% 1.45% 6.57% 1.8% 1.8% 1.8% 1.8%
Net Income 1,632 1,479 2,602 2,649 2,696 2,745 2,794

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 11,477 9,816 9,676 9,836 10,173 10,982 13,445 14,378 13,453 12,274 11,449 10,764
Cost of Revenue 1,960 2,398 2,310 2,533 2,278 2,110 1,805 1,955 1,816 1,630 1,479 1,240
Gross Profit 9,517 7,419 7,366 7,302 7,895 8,872 11,639 12,422 11,637 10,644 9,970 9,523
Gross Margin 82.37% 75.58% 76.12% 74.24% 77.61% 80.79% 86.57% 86.4% 86.5% 86.72% 87.08% 88.48%
Operating Income 4,109 2,274 2,219 2,097 2,902 2,841 4,550 7,043 5,889 5,344 5,150 4,891
Operating Margin 34.76% 23.17% 22.93% 21.32% 28.52% 25.87% 33.84% 48.98% 43.77% 43.54% 44.99% 45.44%
Net Income 2,999 1,479 1,632 1,161 3,047 1,556 4,001 5,888 4,431 2,539 3,703 3,547
Net Margin 25.23% 15.07% 16.87% 11.81% 29.95% 14.17% 29.76% 40.96% 32.93% 20.69% 32.34% 32.95%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 11,477 9,816 9,676 9,836 10,173 10,982 13,445 14,378 13,453 12,274 11,449 10,764
Revenue Growth Rate 1.8% 1.45% -1.62% -3.32% -7.36% -18.32% -6.49% 6.88% 9.61% 7.21% 6.36% 25.42%
Net Income 2,999 1,479 1,632 1,161 3,047 1,556 4,001 5,888 4,431 2,539 3,703 3,547
Net Margin 25.23% 15.07% 16.87% 11.81% 29.95% 14.17% 29.76% 40.96% 32.93% 20.69% 32.34% 32.95%
Net Income Growth Rate 6.65% -9.37% 40.57% -61.89% 95.8% -61.1% -32.06% 32.9% 74.5% -31.43% 4.39% 20.86%
Stockholders Equity 13,091 16,979 16,716 14,799 13,398 10,896 10,700 13,343 13,040 12,613 12,140 9,373
Equity Growth Rate 5.07% 1.57% 12.95% 10.46% 22.96% 1.83% -19.81% 2.33% 3.38% 3.89% 29.52% -13.33%
Return on Invested Capital (ROIC) 17.11% 9.53% 9.43% 8.4% 13.38% 15.91% 18.7% 30.31% 21.5% 14.87% 22.52% 23.68%
After-tax Operating Income 3,200 1,920 1,900 1,878 2,391 2,755 3,656 5,898 4,466 2,782 3,859 3,699
Income Tax Rate 19.86% 15.58% 14.37% 10.43% 17.62% 3.01% 19.66% 16.25% 24.16% 47.94% 25.08% 24.37%
Invested Capital 19,005 20,137 20,146 22,361 17,862 17,318 19,546 19,457 20,769 18,711 17,130 15,619
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us